Last reviewed · How we verify

NCT05597774

Effects of Respiratory Muscle Training in Individuals With Long-term Post-COVID-19 Symptoms

Completed NA Last updated 28 September 2023
What this trial tests

NA trial testing Inspiratory + expiratory muscle training group in Covid19 in 64 participants. Completed in 22 September 2023.

Timeline
28 October 2022
Primary endpoint
22 September 2023
22 September 2023

Quick facts

Lead sponsorUniversidad Complutense de Madrid
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment64
Start date28 October 2022
Primary completion22 September 2023
Estimated completion22 September 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Complutense de Madrid — full company profile →

Who can join

Adults 18 to 100, any sex, with Covid19 or Post-acute COVID-19 Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the present study is to observe the short-term effects of respiratory muscle training combined with an exercise training program on quality of life and exercise tolerance in individuals with long-term post-COVID-19 symptoms. As secondary objectives, the effects on respiratory muscle function, physical and lung function, as well as on the psychological state of these individuals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of respiratory rehabilitation on quality of life in individuals with post-COVID-19 symptoms: A randomised controlled trial.
    Del Corral T, Fabero-Garrido R, Plaza-Manzano G, Izquierdo-García J, et al · · 2025 · cited 6× · PMID 39798250 · DOI 10.1016/j.rehab.2024.101920

Verify or expand the search:

Other trials of Inspiratory + expiratory muscle training group

Trials testing the same drug.

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Universidad Complutense de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05597774.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing